Cannabinoid-1 receptor (CB1R) blockers as medicines: beyond obesity and cardiometabolic disorders to substance abuse/drug addiction with CB1R neutral antagonists.
about
Cannabinoid receptor type-1: breaking the dogmasNew horizons on the role of cannabinoid CB1 receptors in palatable food intake, obesity and related dysmetabolismDesign, synthesis, and biological evaluation of aminoalkylindole derivatives as cannabinoid receptor ligands with potential for treatment of alcohol abuse.Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding Probe.Novel Electrophilic and Photoaffinity Covalent Probes for Mapping the Cannabinoid 1 Receptor Allosteric Site(s).(4-(Bis(4-fluorophenyl)methyl)piperazin-1-yl)(cyclohexyl)methanone hydrochloride (LDK1229): a new cannabinoid CB1 receptor inverse agonist from the class of benzhydryl piperazine analogs.A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol with potential anti-obesity effectsEndocannabinoids and energy homeostasis: an update.Medications development for substance-use disorders: contextual influences (dis)incentivizing pharmaceutical-industry positioning.Insights into the structural biology of G-protein coupled receptors impacts drug design for central nervous system neurodegenerative processes.Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.Functional selectivity at G-protein coupled receptors: Advancing cannabinoid receptors as drug targets.Cannabimimetic phytochemicals in the diet - an evolutionary link to food selection and metabolic stress adaptation?Characterization of the intrinsic activity for a novel class of cannabinoid receptor ligands: Indole quinuclidine analogs.Novel analogs of PSNCBAM-1 as allosteric modulators of cannabinoid CB1 receptor.Peripheral CB1 Receptor Neutral Antagonist, AM6545, Ameliorates Hypometabolic Obesity and Improves Adipokine Secretion in Monosodium Glutamate Induced Obese Mice.
P2860
Q26745261-01879329-9B2D-4520-83E7-0D4F43E8754AQ28833783-0177E427-22CF-4C9E-8214-311C4E12C826Q30569742-621C3571-FBA5-46C8-816E-9FA438CFCE13Q30842363-856675FE-C319-48E6-A71C-9BB728891400Q34500324-171534A0-E98B-421C-96D2-1D0A036FAB39Q34946743-059F253A-C116-4BBD-A6AD-D0EF5734CADFQ36943231-B1E71B4C-E213-41DB-BE28-35FE2625EB05Q38206159-EF854704-ABBD-4C14-8030-2F09A056F2CBQ38243819-4A3358FE-3FFC-4D7C-934C-255BD0CD080DQ38247995-A144ADC3-E12F-4FDA-A969-25E42F8027FAQ38973739-AD0D830E-4465-4DC1-8B35-083284A7B098Q39021630-00260B5A-BB17-4DB2-9C22-DEDF97B42FBCQ39021787-796D19A6-D033-4897-9C84-C191C27E74F7Q43214296-9E34D590-F1DC-494C-AE96-520DBA8B30B8Q47593740-214735A1-855A-4840-B811-84745D475219Q55049564-62611942-8433-483C-8DEB-3A88469D1697
P2860
Cannabinoid-1 receptor (CB1R) blockers as medicines: beyond obesity and cardiometabolic disorders to substance abuse/drug addiction with CB1R neutral antagonists.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cannabinoid-1 receptor (CB1R) ...... with CB1R neutral antagonists.
@en
Cannabinoid-1 receptor
@nl
type
label
Cannabinoid-1 receptor (CB1R) ...... with CB1R neutral antagonists.
@en
Cannabinoid-1 receptor
@nl
prefLabel
Cannabinoid-1 receptor (CB1R) ...... with CB1R neutral antagonists.
@en
Cannabinoid-1 receptor
@nl
P2860
P921
P1476
Cannabinoid-1 receptor (CB1R) ...... with CB1R neutral antagonists.
@en
P2093
David R Janero
P2860
P356
10.1517/14728214.2012.660916
P407
P577
2012-02-16T00:00:00Z